Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 964578, 7 pages
http://dx.doi.org/10.1155/2014/964578
Research Article

Prescribing Multiple Neurostimulants during Rehabilitation for Severe Brain Injury

1Edward Hines Jr. VA Hospital Research Service, P.O. Box 5000, S. Fifth Avenue (M/C 151H), Hines, IL 60141, USA
2The Department of Veterans Affairs (VA), Center of Innovation for Complex Chronic Healthcare, Edward Hines Jr. VA Hospital, P.O. Box 5000, S. Fifth Avenue (M/C 151H), Hines, IL 60141, USA
3Department of Psychiatry & Behavioral Sciences, Northwestern University Feinberg School of Medicine, 710 N Lake Shore Drive Chicago, IL 60611, USA
4Department of Physical Medicine and Rehabilitation, Northwestern University Feinberg School of Medicine, Office of Medical Education (1574), 345 E. Superior Street Chicago, IL 60611, USA
5Research Department, Marianjoy Rehabilitation Hospital, 26W171 Roosevelt Road, Wheaton, IL 60187, USA
6Department of Clinical Research and Leadership, The George Washington University, 2100 Pennsylvania Avenue, Washington, DC 20037, USA
7Department of Biobehavioral Health Science, College of Nursing, University of Illinois at Chicago, 845 S. Damen Avenue, Room 716, Chicago, IL 60612, USA

Received 29 August 2014; Revised 26 November 2014; Accepted 30 November 2014; Published 22 December 2014

Academic Editor: Gabriel Y. F. Ng

Copyright © 2014 Amy A. Herrold et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Andrews, “The vegetative state—clinical diagnosis,” Postgraduate Medical Journal, vol. 75, no. 884, pp. 321–324, 1999. View at Google Scholar · View at Scopus
  2. J. T. Giacino, “Disorders of consciousness: differential diagnosis and neuropathologic features,” Seminars in Neurology, vol. 17, no. 2, pp. 105–111, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. J. T. Giacino, S. Ashwal, N. Childs et al., “The minimally conscious state: definition and diagnostic criteria,” Neurology, vol. 58, no. 3, pp. 349–353, 2002. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Plum and J. Posner, The Diagnosis of Stupor and Coma, FA Davis Co, Philadelphia, Pa, USA, 3rd edition, 1980.
  5. B. Jennett, “A quarter century of the vegetative state: an international perspective,” The Journal of Head Trauma Rehabilitation, vol. 12, no. 4, pp. 1–12, 1997. View at Google Scholar · View at Scopus
  6. The Multi-Society Task Force on PVS, “Medical aspects of the persistent vegetative state,” The New England Journal of Medicine, vol. 330, no. 21, pp. 1499–1579, 1994. View at Publisher · View at Google Scholar
  7. J. Whyte, M. Vaccaro, P. Grieb-Neff, and T. Hart, “Psychostimulant use in the rehabilitation of individuals with traumatic brain injury,” Journal of Head Trauma Rehabilitation, vol. 17, no. 4, pp. 284–299, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. R. DeMarchi, V. Bansal, A. Hung et al., “Review of awakening agents,” The Canadian Journal of Neurological Sciences, vol. 32, no. 1, pp. 4–17, 2005. View at Google Scholar · View at Scopus
  9. N. D. Volkow, G.-J. Wang, J. S. Fowler et al., “Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate,” The American Journal of Psychiatry, vol. 155, no. 10, pp. 1325–1331, 1998. View at Google Scholar · View at Scopus
  10. M. Peeters, G. Page, J.-M. Maloteaux, and E. Hermans, “Hypersensitivity of dopamine transmission in the rat striatum after treatment with the NMDA receptor antagonist amantadine,” Brain Research, vol. 949, no. 1-2, pp. 32–41, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Hökfelt and K. Fuxe, “Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.,” Neuroendocrinology, vol. 9, no. 2, pp. 100–122, 1972. View at Publisher · View at Google Scholar · View at Scopus
  12. A. M. Johnson, D. M. Loew, and J. M. Vigouret, “Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+) amphetamine and l DOPA,” British Journal of Pharmacology, vol. 56, no. 1, pp. 59–68, 1976. View at Publisher · View at Google Scholar · View at Scopus
  13. D. Zolkowska, R. Jain, R. B. Rothman et al., “Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil,” Journal of Pharmacology and Experimental Therapeutics, vol. 329, no. 2, pp. 738–746, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. L. Ferraro, T. Antonelli, S. Beggiato, M. C. Tomasini, K. Fuxe, and S. Tanganelli, “The vigilance promoting drug modafinil modulates serotonin transmission in the rat prefrontal cortex and dorsal raphe nucleus. Possible relevance for its postulated antidepressant activity,” Mini-Reviews in Medicinal Chemistry, vol. 13, no. 4, pp. 478–492, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. J. T. Giacino, J. Whyte, E. Bagiella et al., “Placebo-controlled trial of amantadine for severe traumatic brain injury,” The New England Journal of Medicine, vol. 366, no. 9, pp. 819–826, 2012. View at Publisher · View at Google Scholar · View at Scopus
  16. R. Forsyth and B. Jayamoni, “Noradrenergic agonists for acute traumatic brain injury,” Cochrane Database of Systematic Reviews, no. 1, Article ID CD003984, 2003. View at Google Scholar · View at Scopus
  17. T. L.-B. Pape, A. W. Heinemann, J. P. Kelly, A. G. Hurder, and S. Lundgren, “A measure of neurobehavioral functioning after coma. Part I: theory, reliability, and validity of the disorders of consciousness scale,” Journal of Rehabilitation Research and Development, vol. 42, no. 1, pp. 1–18, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. T. L.-B. Pape, R. G. Senno, A. Guernon, and J. P. Kelly, “A measure of neurobehavioral functioning after coma. Part II: clinical and scientific implementation,” Journal of Rehabilitation Research and Development, vol. 42, no. 1, pp. 19–28, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. T. L. Pape, T. Mallinson, and A. Guernon, “Psychometric properties of the disorders of consciousness scale,” Archives of Physical Medicine and Rehabilitation, vol. 95, no. 9, pp. 1672–1684, 2014. View at Publisher · View at Google Scholar
  20. T. Pape, S. Lundgren, A. Guernon, J. Kelly, and A. Heinemann, Disorders of Conciousness Scale (DOCS): Administration Manual, US Department of Veterans Affairs, 2011.
  21. T. Mallinson, T. Pape, and A. Guernon, “Responsiveness, minimal detectable change, and minimally clinically important differences of the disorders of consciousness scale,” Archives of Physical Medicine and Rehabilitation, vol. 94, no. 10, pp. e43–e44, 2013. View at Google Scholar
  22. T. L.-B. Pape, C. Tang, A. Guernon et al., “Predictive value of the disorders of consciousness scale (DOCS),” PM&R, vol. 1, no. 2, pp. 152–161, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. T. L.-B. Pape, A. Guernon, S. Lundgren et al., “Predicting levels of independence with expressing needs and ideas 1 year after severe brain injury,” Rehabilitation Psychology, vol. 58, no. 3, pp. 253–262, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. J. M. Linacre, Many-Facet Rasch Measurement, Mesa Press, Chicago, Ill, USA, 1994.
  25. R. Fisher, “Theory of statistical estimation,” Proceedings of the Cambridge Philosophical Society, vol. 22, pp. 700–725, 1925. View at Google Scholar
  26. G. Rasch, Probabilistic Models for Some Intelligence and Attainment Tests, Expanded Edition, Danish Institute for Educational Research, Copenhagen, Denmark, University of Chicago Press, Chicago, Ill, USA, 1980.
  27. B. Wright and G. Masters, Rating Scale Analysis, University of Chicago, MESA Press, Chicago, Ill, USA, 1982.
  28. S. Ganesh, A. Guernon, L. Chalcraft, B. Harton, B. Smith, and T. Louise-Bender Pape, “Medical comorbidities in disorders of consciousness patients and their association with functional outcomes,” Archives of Physical Medicine and Rehabilitation, vol. 94, no. 10, pp. 1899.e3–1907.e3, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. P. R. Yarnold and R. C. Soltysik, Optimal Data Analysis: A Guidebook with Software for Windows, American Psychological Association, Washington, DC, USA, 2005.
  30. B. Efron and R. Tibshirani, “Improvements on cross-validation: the .632+ bootstrap method,” The Journal of the American Statistical Association, vol. 92, no. 438, pp. 548–560, 1997. View at Google Scholar · View at Scopus
  31. E. A. Fridman, Off-Label Use of Stimulants in Vegetative State and Minimally Conscious State, IBIA, 2014.
  32. J. Whyte, D. Katz, D. Long et al., “Predictors of outcome in prolonged posttraumatic disorders of consciousness and assessment of medication effects: a multicenter study,” Archives of Physical Medicine and Rehabilitation, vol. 86, no. 3, pp. 453–462, 2005. View at Publisher · View at Google Scholar · View at Scopus
  33. R. T. Seel, M. Sherer, J. Whyte et al., “Assessment scales for disorders of consciousness: Eevidence-based recommendations for clinical practice and research,” Archives of Physical Medicine and Rehabilitation, vol. 91, no. 12, pp. 1795–1813, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. M. Rappaport, The Coma/Near Coma Scale. The Center for Outcome Measurement in Brain Injury, 2000.
  35. J. T. Giacino, K. Kalmar, and J. Whyte, “The JFK coma recovery scale-Revised: measurement characteristics and diagnostic utility,” Archives of Physical Medicine and Rehabilitation, vol. 85, no. 12, pp. 2020–2029, 2004. View at Publisher · View at Google Scholar · View at Scopus
  36. M. Rappaport, K. M. Hall, K. Hopkins, T. Belleza, and D. N. Cope, “Disability rating scale for severe head trauma: coma to community,” Archives of Physical Medicine and Rehabilitation, vol. 63, no. 3, pp. 118–123, 1982. View at Google Scholar · View at Scopus
  37. A. Marchetti, R. Magar, H. Lau et al., “Pharmacotherapies for attention-deficit/hyperactivity disorder: expected-cost analysis,” Clinical Therapeutics, vol. 23, no. 11, pp. 1904–1921, 2001. View at Publisher · View at Google Scholar · View at Scopus